Effect of anticoagulant treatment on deep vein thrombosis post-endovenous radiofrequency catheter ablation

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-17010898

Enrollment

Unknown

Registered

2017-03-16

Start date

2017-03-20

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous thrombosis

Interventions

anticoagulant group:intravenous injection of 3,000 U of heparin immediately after the sheath puncture, and was followed by an additional 1,000 U of heparin for the subsequent each hour.

non-anticoagulant group:not given heparin injection

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: with paroxysmal supraventricular tachycardia (including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia, and focal atrial tachycardia) required only endovenous RFCA.

Exclusion criteria

Exclusion criteria: patients with bleeding disorders in which anticoagulant therapy could not be tolerated, patients with thrombosis prior to the surgery, patients with significantly unusual liver and kidney functions, and patients with severe cardiopulmonary dysfunction.

Design outcomes

Primary

Measure	Time frame
Venous thrombosis;	—

Countries

China

Contacts

Public ContactJie Fan

The first people‘s Hospital of Yunnan Province

fanj913@sina.com+86 13608811433

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026